Centre for Innovative Research in Medical and Natural Sciences' Medical Faculty of University of Rzeszow
Rzeszów, Podkarpackie Voivodeship, 35-310, Poland
NCT Number: NCT04013308
The aim of the study: To assess the influence of iontophoresis treatment with 2% potassium iodide on the level of thyroid hormones (TSH, FT3, FT4) The study group: conducting 10 iontophoresis treatments with Potassium iodide; The control group: conducting 10 placebo treatments with iontophoresis with destilled water; Intervention: 10 iontophoresis treatments with 2% potassium iodide in healthy individuals.
Test the level of thyroid hormones before and after the 10 iontophoresis treatments; The study allows to assess the influence of iodine on the function of thuroid gland.
Looking for future studies?
Notify Me19 year–23 year
All sexes
Interventional
Not applicable
Rzeszów, Podkarpackie Voivodeship, 35-310, Poland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
10 iontophoresis treatments with 2% potassium iodide on the area of thyroid gland; electrodes with tin foil (Amperage:2mA, duration: 30min)
Time frame: change in the thyroid hormones level from the baseline to 14 days after the last treatment
to test thyroid hormones before and after 10 iontophoresis treatments
University of Rzeszow
Other
Iontophoresis With Potassium Iodide and the Level of Thyroid Hormones in Healthy Subjects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05385029
Endocrine System Diseases, Hyperthyroidism
Riyadh, Central, Saudi Arabia
View Trial DetailsNCT04565873
Pregnancy Early, Pregnancy Related
Amman, Jordan
View Trial DetailsNCT04470440
Immune Checkpoint Inhibitor, Non Small Cell Lung Cancer Metastatic
Brest, France
View Trial DetailsNCT02500342
Behavior, Behavioral Symptoms
Cork, Ireland
View Trial Details